WO2007016929A1 - Method for preparation of dna ladder using pcr and its optimization by numerical modeling thereof - Google Patents
Method for preparation of dna ladder using pcr and its optimization by numerical modeling thereof Download PDFInfo
- Publication number
- WO2007016929A1 WO2007016929A1 PCT/EG2006/000015 EG2006000015W WO2007016929A1 WO 2007016929 A1 WO2007016929 A1 WO 2007016929A1 EG 2006000015 W EG2006000015 W EG 2006000015W WO 2007016929 A1 WO2007016929 A1 WO 2007016929A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna
- pcr
- length
- primers
- fragments
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 238000005457 optimization Methods 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title description 4
- 239000012634 fragment Substances 0.000 claims abstract description 30
- 239000013612 plasmid Substances 0.000 claims abstract description 10
- 230000003321 amplification Effects 0.000 claims abstract description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 6
- 239000011777 magnesium Substances 0.000 claims description 10
- 238000000137 annealing Methods 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 238000010993 response surface methodology Methods 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 238000000611 regression analysis Methods 0.000 claims 1
- 238000003752 polymerase chain reaction Methods 0.000 abstract description 21
- 239000003155 DNA primer Substances 0.000 abstract 1
- 239000012847 fine chemical Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 29
- 239000011543 agarose gel Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Definitions
- the patent pending is in the field of molecular biology.
- the request of invention relates to a method for preparing a DNA ladder in the range (100 - 2500) base with ten marker fragments by applying the polymerase chain reaction.
- optimization of the PCR yield by applying numerical modeling.
- DNA ladders are common reagents in molecular biology, useful for determining the size of DNA fragments.
- a DNA ladder comprises two or more DNA fragments of known size.
- a DNA sample and a DNA ladder are loaded in adjacent wells of an agarose gel.
- the DNA is separated by electrophoresis through the gel.
- the gel is stained with a flourescent dye, such as ethidium bromide, and exposed to ultraviolet light.
- the size of the sample DNA fragments are determined by comparing their migration with the bands of known size in the DNA ladder.
- DNA ladders are commercially available from numerous vendors, including Sigma, Pharmacia, Life Technologies, Promega, Boerhinger-Mannheim, Amersham, New England Biolabs, Stratagene, and Invitrogen.
- the special plasmid contains an insert of tandem repeats of a DNA fragment.
- the same unique restriction site lies at each junction of the repeat units. Partial restriction digestion of this plasmid produces a ladder containing multimers of the repeated DNA fragment.
- DNA ladder preparation is the restriction digestion of ⁇ phage viruse with an appropriate restriction enzyme to create DNA fragments with specified lengthes depending on the restriction enzyme used.
- PCR polymerase chain reaction
- oligonucleotides representing one forward and ten reverse primers, was designed based on the sequence of the template DNA used (plasmid DNA).
- sequence of the primers is represented as follows:
- AGAGGCCCCAAGGfiGTTAT R1 : GGCCGCTCGAGCAGATC
- R2 ACAGCAAATGGGTCGGGAT
- R3 CGAAATTAATACGACTCACTAT
- R4 GGCAACCCCGCCAGCCTA
- R5 ACCGAAGACCATTCATGTTGT
- R6 GAGAGAGGATGCTCACGAT
- R7 TGTCAGAGGTTTTCACCGTC
- R8 TGTCGGGTTTCGCCACCT
- CTGCGCGTAATCTGCTGCT R10: TGTAACTCGCCTTGATCGTT
- Fig. 1 illustrates the DNA sequence of the plasmid used as target DNA along with the location of primers annealing.
- Preliminary amplification reactions (50 ⁇ l) were done as follows : 25 ⁇ l of 2X PCR master mix; 25 pmoles of each primer; 50 ng of template DNA. This method is characterized by its ease of application beside low price of chemicals (which are no longer expensive biochemicals). Besides, it gives the possibility and flexibility of producer to creat landmark fragments within the ladder by increasing the concentration of specified fragments upon mixing. Moreover, it facilitates the preparation of customised ladder rather than defaulted one.
- Fig. 3-A represents 2% agarose gel electrophoresis of the PCR amplified fragments that constitutes the DNA synthesized marker.
- the second part of this work describes a method for optimization of PCR product by applying numerical modeling and statistically designed experiments.
- This method could be an economical method for increasingt he yield of PCR product specially when PCR yield is a target response as in the present case (DNA ladder).
- a response surface methodology based on numerical modeling was applied to optimize the production of 2 Kb fragment (which has been showed lower yield of production in comparison with other fragments).
- a Box-Behnken design (1960) based on response surface methodology was applied.
- Six variables were tested in this experiment, namely: primers concentration, number of cycles, Taq concentration, magnesium concentration, annealing temperature, and extension time.
- Table 1 represents the design matrix of a 46 trials experiment with the real values of the tested variables, where factors were prescribed into three settings, middle and high concentrations (or values).
- Annealing primer annealing temperature
- Fig. 2 illustrates the three dimensional surface response showing the correlation between studied variables and the PCR yield (response).
- Fig. 3-B illustrates the prepared DNA marker after optimization on running in electrophoresis 2% agarose gel with different concentrations (400-2000 ng).
- Fig. 1 Tamplate DNA plasmid sequence representing target amplification sites (highlighted).
- F1 represents the forward primer
- R1-R10 representing the corresponding reverse primers for the ten PCR reactions.
- Fig. 2 Three-dimensional surface plots representing the correlation between independent variables and the PCR yield.
- Fig. 3A 1 % agarose gel representing basal PCR amplification of the tempelate plasmid uding the primer set to prepare the 100 base DNA ladder .
- Fig. 3B 1% agarose gel representing different concentrations of final product 100 base DNA ladder.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The patent pending describes an easy method for preparing DNA ladder using polymerase chain reaction and, consequently, applying numerical modeling for optimization of PCR yield. In this method (11) oligonucleotide primers have been design to amplify (10) DNA fragments from plasmid DNA with known lengths. Based on the required fragment lengths, three PCR programs have been implemented to give the best amplification results. In order to optimize the PCR yield, numerical modeling methodology has been applied by studying (6) significant variables simultaneously. The optimized PCR yield reached (5) times the basal conditions. In addition, a mathematical equation has been described to correlate the relationship between variables and the PCR yield which saves time and fine chemicals consumption.
Description
TITLE OF INVENTION
Method for preparation of DNA ladder using PCR and its optimization by numerical modeling thereof
Technical field
The patent pending is in the field of molecular biology. In particular, the request of invention relates to a method for preparing a DNA ladder in the range (100 - 2500) base with ten marker fragments by applying the polymerase chain reaction. Moreover, optimization of the PCR yield by applying numerical modeling.
Background Art
DNA ladders are common reagents in molecular biology, useful for determining the size of DNA fragments. A DNA ladder comprises two or more DNA fragments of known size. Typically, a DNA sample and a DNA ladder are loaded in adjacent wells of an agarose gel. The DNA is separated by electrophoresis through the gel. The gel is stained with a flourescent dye, such as ethidium bromide, and exposed to ultraviolet light. The size of the sample DNA fragments are determined by comparing their migration with the bands of known size in the DNA ladder. DNA ladders are commercially available from numerous vendors, including Sigma, Pharmacia, Life Technologies, Promega, Boerhinger-Mannheim, Amersham, New England Biolabs, Stratagene, and Invitrogen.
One established method for manufacturing a DNA ladder is by partial restriction digestion of a special plasmid. The special plasmid contains an insert of tandem repeats of a DNA fragment. The same unique restriction site lies at each junction of the repeat units. Partial restriction digestion of this plasmid produces a ladder containing multimers of the repeated DNA fragment.
Another method for DNA ladder preparation is the restriction digestion of λ phage viruse with an appropriate restriction enzyme to create DNA fragments with specified lengthes depending on the restriction enzyme used.
In the first method there are disadvantages refererring to the tedious cloning experiments which must be done to construct the vector with several tandom repeats beside the unreproducibility of restriction digestion resulting in variable yield each time. In the second method the ladder fragments sizes are not fully controlled as it relies on the used restriction enzyme.
Disclosure of the Invention
A method for preparing a DNA Ladder using polymerase chain reaction (PCR) and the optimization of the amplification reaction therof by applying numerical modeling experimental design.
For the amplification of DNA ladder fragments a set of oligonucleotides, representing one forward and ten reverse primers, was designed based on the sequence of the template DNA used (plasmid DNA). The sequence of the primers is represented as follows:
F1 : AGAGGCCCCAAGGfiGTTAT R1 : GGCCGCTCGAGCAGATC R2: ACAGCAAATGGGTCGGGAT R3: CGAAATTAATACGACTCACTAT R4: GGCAACCCCGCCAGCCTA R5: ACCGAAGACCATTCATGTTGT R6: GAGAGAGGATGCTCACGAT R7: TGTCAGAGGTTTTCACCGTC R8: TGTCGGGTTTCGCCACCT R9: CTGCGCGTAATCTGCTGCT R10: TGTAACTCGCCTTGATCGTT
Fig. 1 illustrates the DNA sequence of the plasmid used as target DNA along with the location of primers annealing. By applying simple PCR 10 DNA fragments with different sizes were amplified, where different operation programs for PCR were constructed based on the required fragments' length. PCR operation programs are listed as follows:
1. For fragment lengths 100-500 base
T = 94°C 5 minutes
30 cycles as follows:
T = 94°C 45 second
T = 53°C 45 second
T = 72°C 45 second
Then Hold 4°C
2. For fragment lengths 750-1500 base T = 940C 5 minutes
30 cycles as follows: T = 940C 1 minute
T = 53°C 1 minute
T = 720C 105 second
Then Hold 4°C
3. For fragment lengths 2000-2500 base T = 94°C 5 minutes
30 cycles as follows: T = 94°C 1 minute
T = 53°C 1 minute
T = 720C 150 second
Then Hold 4°C
Preliminary amplification reactions (50 μl) were done as follows : 25 μl of 2X PCR master mix; 25 pmoles of each primer; 50 ng of template DNA. This method is characterized by its ease of application beside low price of chemicals (which are no longer expensive biochemicals). Besides, it gives the possibility and flexibility of producer to creat landmark fragments within the ladder by increasing the concentration of specified fragments upon mixing. Moreover, it facilitates the preparation of customised ladder rather than defaulted one.
Fig. 3-A represents 2% agarose gel electrophoresis of the PCR amplified fragments that constitutes the DNA synthesized marker.
The second part of this work describes a method for optimization of PCR product by applying numerical modeling and statistically designed experiments. This method could be an economical method for increasingt he yield of PCR product specially when PCR yield is a target response as in the present case (DNA ladder). For example, a response surface methodology based on numerical modeling was applied to optimize the production of 2 Kb fragment (which has been showed lower yield of production in comparison with other fragments).
In order to describe the nature of the response surface and the interactions between variables under experimental constraints, a Box-Behnken design (1960) based on response surface methodology was applied. Six variables were tested in this experiment, namely: primers concentration, number of cycles, Taq concentration, magnesium concentration, annealing temperature, and extension time. Table 1 , represents the design matrix of a 46 trials experiment with the real values of the tested variables, where factors were prescribed into three settings, middle and high concentrations (or values).
For predicting the optimal point, within experimental constrains, a second-order polynomial function was fitted to the experimental results (linear optimization algorithm) of PCR yield:
YpcR yield = 189.3+2.5*primer+26.44*cycles+18*Taq+5.2*Mg+3.9*Annealing-
5.1 *Extension-0.25*primer*cycles-17.84*primers*Taq-10.14*cycles*Taq-
10.58*primers*Mg+7.8*cycles*Mg-24.85*Taq*Mg+8.4*primers*Extension-
11.96*cycles*Annealing+9.4*Taq*Annealing-
3.14*Mg*Annealing+0.48*primers*Extension+0.05*cycles*Extension-
13.4*Taq*Extension-20.64*Mg*Extension-8.7*Annealing*Extension-
0.18*primers*primers-7.18*cycles*cycles-10.77*Taq*Taq-
29.9*Mg*Mg+5.86*Anealing*Anealing-28*Extension*Extension
Where:
Primers = primer concentration
Cycles = number of PCR cycles
Taq = enzyme concentration
Mg = MgCb concentration
Annealing = primer annealing temperature
Extension = extension time
Fig. 2 illustrates the three dimensional surface response showing the correlation between studied variables and the PCR yield (response). On mathematical calculation of the previously mentioned polynomial equation ( within the experimental constraints) maximum PCR yield for amplifying the 2 Kb fragment ( more than 5 folds the initial conditions) was attained under the following conditions: Primer concentration 10 pmole
Taq concentration 2.4 U/50μl reaction
MgCb concentration 2.2 mM
Number of cycles 30 cycle
Annealing temperature 53°C
Extension time 1.4 minutes
Fig. 3-B illustrates the prepared DNA marker after optimization on running in electrophoresis 2% agarose gel with different concentrations (400-2000 ng).
Figures and Table legends
Fig. 1. Tamplate DNA plasmid sequence representing target amplification sites (highlighted). F1 represents the forward primer, R1-R10 representing the corresponding reverse primers for the ten PCR reactions.
Fig. 2. Three-dimensional surface plots representing the correlation between independent variables and the PCR yield.
Fig. 3A. 1 % agarose gel representing basal PCR amplification of the tempelate plasmid uding the primer set to prepare the 100 base DNA ladder .
Fig. 3B. 1% agarose gel representing different concentrations of final product 100 base DNA ladder.
Table 1. Real values of experimental variables used in the Box-Behnken design matrix for optimization of PCR yield.
Claims
1. A method for making a DNA ladder, by PCR amplification of plasmid DNA with known sequence using a set of eleven primers, whereby:
(a) Only one forward primer (F1) is used and the other ten primers are reverse (R1-R10);
(b) the length between each pair of primers is an integer multiple of a minimal length for fragments 100-500 base, said minimal length is the length between the start of the forward primer and the end of the reverse primer;
(c) the PCR amplification generates a DNA ladder with ten differently sized DNA fragments; and
(d) said DNA ladder has the properties that (i) all DNA fragments of the ladder have lengths which are integer multiples of the minimal length (100 base which results from PCR amplification using F1and R1 primers); (ii) the smallest DNA fragment length is the minimal amplification length; and (iii) the largest DNA fragment is the length of the entire plasmid;
2. A method according to claim 1 , for optimization of the PCR yield of the 2 Kb fragment, which was obtained weak in comparison with other fragments, by applying response surface methodology and numerical modeling, whereby:
(a) Six variables were tested namely: primers concentration, number of cycles, Taq concentration, magnesium concentration, annealing temperature, and extension time;
(b) A 46 trials design matrix was carried out and the intensity of the fragment was considered as response;
(c) A standard regression analysis of the matrix was applied to calculate the regression coefficients of the structured polynomial model; (d) Three folds PCR yield was achieved after solving the polynomial within the experimental constraints.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EG2005080359A EG24237A (en) | 2005-08-09 | 2005-08-09 | Method for preparation of dna ladder using pcr andits optimization by numerical modeling thereof |
EG2005080359 | 2005-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007016929A1 true WO2007016929A1 (en) | 2007-02-15 |
Family
ID=43857853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EG2006/000015 WO2007016929A1 (en) | 2005-08-09 | 2006-04-03 | Method for preparation of dna ladder using pcr and its optimization by numerical modeling thereof |
Country Status (2)
Country | Link |
---|---|
EG (1) | EG24237A (en) |
WO (1) | WO2007016929A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011971A1 (en) * | 1993-10-28 | 1995-05-04 | Life Technologies, Inc. | Nucleic acid marker ladder for estimating mass |
US5824787A (en) * | 1993-12-03 | 1998-10-20 | Gensura Laboratories, Inc. | Polynucleotide sizing reagent |
WO1999003872A1 (en) * | 1997-07-15 | 1999-01-28 | Life Technologies, Inc. | Nucleic acid ladders |
WO2004063322A2 (en) * | 2003-01-13 | 2004-07-29 | Seegene, Inc. | Dna size markers and method for preparing them |
-
2005
- 2005-08-09 EG EG2005080359A patent/EG24237A/en active
-
2006
- 2006-04-03 WO PCT/EG2006/000015 patent/WO2007016929A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011971A1 (en) * | 1993-10-28 | 1995-05-04 | Life Technologies, Inc. | Nucleic acid marker ladder for estimating mass |
US5824787A (en) * | 1993-12-03 | 1998-10-20 | Gensura Laboratories, Inc. | Polynucleotide sizing reagent |
WO1999003872A1 (en) * | 1997-07-15 | 1999-01-28 | Life Technologies, Inc. | Nucleic acid ladders |
WO2004063322A2 (en) * | 2003-01-13 | 2004-07-29 | Seegene, Inc. | Dna size markers and method for preparing them |
Also Published As
Publication number | Publication date |
---|---|
EG24237A (en) | 2008-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9469874B2 (en) | Long-range barcode labeling-sequencing | |
EP1987159B1 (en) | Method for sequencing a polynucleotide template | |
US20120244525A1 (en) | Oligonucleotide Adapters: Compositions and Methods of Use | |
US20120238738A1 (en) | Oligonucleotide Adapters: Compositions and Methods of Use | |
EP2058396A1 (en) | Nucleic acid amplification method | |
BR0014182A (en) | Processes and compositions for linear isothermal amplification of polynucleotide sequences | |
EP2191011A1 (en) | Method for sequencing a polynucleotide template | |
JP2010539956A5 (en) | ||
AR030961A1 (en) | SEQUENCES OF NUCLEOTIDES INTERVENING IN MALE FERTILITY IN PLANTS AND METHOD OF USE OF THE SAME | |
JP2015533296A5 (en) | ||
WO2010038042A1 (en) | Nucleic acid sample enrichment for sequencing applications | |
WO2010064893A1 (en) | Method for the reduction of repetitive sequences in adapter-ligated restriction fragments | |
ATE485391T1 (en) | COMPOSITIONS, METHODS AND TEST SYSTEMS FOR DETERMINING THE PRESENCE OF CRYPTOSPORIDIUM ORGANISMS IN A TEST SAMPLE | |
WO2002083943A3 (en) | Microarray method for enriching dna fragments from complex mixtures | |
MX2021014430A (en) | Method of amplifying mrnas and for preparing full length mrna libraries. | |
Sun et al. | Characterization of self-assembled DNA concatemers from synthetic oligonucleotides | |
WO2007016929A1 (en) | Method for preparation of dna ladder using pcr and its optimization by numerical modeling thereof | |
EP3969581B1 (en) | Capture and analysis of target genomic regions | |
Murray et al. | The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences | |
WO2018221240A1 (en) | Novel fluorescence quenching probe for measuring nucleic acid | |
WO2004097003A3 (en) | Multiply-primed amplification of nucleic acid sequences | |
ATE420975T1 (en) | METHOD FOR LINEAR NON-SELECTIVE AMPLIFICATION OF NUCLEIC ACIDS | |
AR109017A1 (en) | METHODS FOR USING LONG SINGLE CHAIN DNA POLYUCLEOTIDES AS PRIMERS IN PCR TESTS | |
WO2000055361A3 (en) | Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method | |
KR101860785B1 (en) | Specific primer set for detecting Curtobacterium flaccumfaciens pv. flaccumfaciens, quarantine plant pathogen and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06706156 Country of ref document: EP Kind code of ref document: A1 |